Potentiation of doxorubicin-induced apoptosis and differentiation by indomethacin in K-562 leukemia cells

Neoplasma

Volumn 51, Issue 3, 2004, Pages 188-192

  Cipak L ^a   Paulikova H ^b   Novotny L ^c   Jarosova M ^b   Rauko, P ^a  

^a Cancer Research Institute   (Slovakia)

^b SLOVAK UNIVERSITY OF TECHNOLOGY   (Slovakia)

^c KUWAIT UNIVERSITY   (Kuwait)

Author keywords

Apoptosis; Differentiation; Doxorubicin; GSH; Indomethacin; Synergism

Indexed keywords

DOXORUBICIN; GLUTATHIONE; INDOMETACIN;

ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; CANCER COMBINATION CHEMOTHERAPY; CANCER GROWTH; CELL DIFFERENTIATION; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG EFFICACY; DRUG POTENTIATION; HUMAN; HUMAN CELL; LEUKEMIA CELL;

EID: 3042677681     PISSN: 00282685     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (19)

1. BUNCE CM, MOUNTFORD JC, FRENCH PJ, MOLE DJ, DURHAM J et al. Potentiation of myeloid differentiation by anti-inflammatory agents, by steroids and by retinoic acid involves a single intracellular target, probably an enzyme of the aldoketoreductase family. Biochim Biophys Acta 1996; 1311: 189-198.
2. CARLBERG I, MANNERVIK B. Glutathione reductase. Methods Enzymol 1985; 113: 484-490.
3. COURAGE C, BUDWORTH J, GESCHER A. Comparison of ability of protein kinase C inhibitors to arrest cell growth and to alter cellular protein kinase C localisation. Br J Cancer 1995; 71: 697-704.
4. DETJEN KM, WELZEL M, WIEDENMANN B, ROSEWICZ S. Non-steroidal anti-inflammatory drugs inhibit growth of human neuroendocrine tumor cells via G1 cell-cycle arrest. Int J Cancer 2003; 107: 844-853.
5. EVANS DL, TILBY M, DIVE C. Differential sensitivity to the induction of apoptosis by cisplatin in proliferating and quiescent immature rat thymocytes is independent of the levels of drug accumulation and DNA adduct formation. Cancer Res 1994; 54: 1596-1603.
6. HABIG WH, JAKOBY WB. Glutathione S-transferases (rat and human). Methods Enzymol 1981; 77: 218-231.
7. HATTORI K, MATSUSHITA R, KIMURA K, ABE Y, NAKASHIMA E. Synergistic effect of indomethacin with adriamycin and cisplatin on tumor growth. Biol Pharm Bull 2001; 24: 1214-1217.
8. CHENAIS B, ANDRIOLLO M, GUIRAUD P, BELHOUSSINE R, JEANNESSON P. Oxidative stress involvement in chemically induced differentiation of K562 cells. Free Radic Biol Med 2000; 28: 18-27.
9. CHOU TC, TALALAY P. Analysis of combined drug effects: a new look at a very old problem. Trends Pharmacol Sci 1983; 4: 450-455.
10. NYOUNG MN, TRENTESAUX C, ARIES A, CARPENTIER Y, JARDILLIER JC et al. Effect of aclacinomycin-doxorubicin association on differentiation and growth of human erythroleukemic K562 cells. Anticancer Res 1994; 14: 1203-1208.
11. SHIFF SJ, KOUTSOS MI, QIAO L, RIGAS B. Nonsteroidal anti-inflammatory drugs inhibit the proliferation of colon adenocarcinoma cells: effects on cell cycle and apoptosis. Exp Cell Res 1996; 222: 179-188.
12. SHIFF SJ, QIAO L, TSAI LL, RIGAS B. Sulindac sulfide, an aspirin-like compound, inhibits proliferation, causes cell cycle quiescence, and induces apoptosis in HT-29 colon adenocarcinoma cells. J Clin Invest 1995; 96: 491-503.
13. SCHAFER FQ, BUETTNER GR. Redox environment of the cell as viewed through the redox state of the glutathione disulfide/glutathione couple. Free Radic Biol Med 2001; 30: 1191-1212.
14. SOKOLOSKI JA, SARTORELLI AC. Induction of the differentiation of HL-60 promyelocytic leukemia cells by nonsteroidal anti-inflammatory agents in combination with low levels of vitamin D3. Leuk Res 1998; 22: 153-161.
15. VANDEPUTTE C, GUIZON I, GENESTIE-DENIS I, VANNIER B, LORENZON G. A microtiter plate assay for total glutathione and glutathione disulfide contents in cultured/isolated cells: performance study of a new miniaturized protocol. Cell Biol Toxicol 1994; 10: 415-421.
16. YALOWICH JC, TYURINA YY, TYURIN VA, ALLAN WP, KAGAN VE. Reduction of phenoxyl radicals of the antitumour agent etoposide (VP-16) by glutathione and protein sulfhydryls in human leukaemia cells: Implications for cytotoxicity. Toxicol in Vitro 1996; 1: 59-68.
17. YIP-SCHNEIDER MT, SWEENEY CJ, JUNG SH, CROWELL PL, MARSHALL MS. Cell cycle effects of nonsteroidal anti-inflammatory drugs and enhanced growth inhibition in combination with gemcitabine in pancreatic carcinoma cells. J Pharmacol Exp Ther 2001; 298: 976-985.
18. ZHANG G, TU C, ZHANG G, ZHOU G, ZHENG W. Indomethacin induces apoptosis and inhibits proliferation in chronic myeloid leukemia cells. Leuk Res 2000; 24: 385-392.
19. ZHOU G, ZHANG G. Indomethacin induces apoptosis of K562 cells through activation of caspases and elevation of intra-cellular free calcium. Zhonghua Xue Ye Xue Za Zhi 2001;